Financial results are a critical indicator of a company's health and future prospects. When a company like Clearside Biomedical reports financial results that are below market expectations, it often leads to a decrease in investor confidence and a subsequent drop in share price. This is particularly true for companies in the biotech sector, where investment is heavily driven by growth prospects and financial performance.